News
2d
Zacks.com on MSNVeracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock?Veracyte (VCYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...
1d
TipRanks on MSNCRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and IridiumAce hedge fund manager Cathie Wood made some interesting trades on July 25, according to ARK Invest’s daily trade updates. Wood sold $16.46 ...
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
On March 7, 2025, Veracyte, Inc. (NASDAQ:VCYT) stock closed at $32.02 per share with a market capitalization of $2.496 billion.
Have you been paying attention to shares of Veracyte (VCYT)? Shares have been on the move with the stock up 27.4% over the past month. The stock hit a new 52-week high of $32.86 in the previous ...
Veracyte Price Performance Shares of NASDAQ:VCYT opened at $31.32 on Tuesday. Veracyte has a 1-year low of $19.73 and a 1-year high of $47.32. The stock has a market cap of $2.45 billion, a P/E ...
Veracyte, Inc. (NASDAQ: VCYT) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Shayla Gorman – Senior Director, Investor Relations Marc Stapley – Chief Executive ...
Veracyte, Inc. (NASDAQ: VCYT) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Shayla Gorman - Senior Director, Investor Relations Marc Stapley - Chief Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results